January 4, 2018 / 12:07 PM / 8 months ago

BRIEF-Merus Provides Clinical Updates For Mcla-117 And Mcla-158 Programs

Jan 4 (Reuters) - Merus Nv:

* MERUS PROVIDES CLINICAL UPDATES FOR MCLA-117 AND MCLA-158 PROGRAMS

* MERUS NV - PLANS TO FILE AN IND FOR MCLA-158 WITH U.S. FDA IN Q1 OF 2018​

* MERUS NV - APPROVAL OF CLINICAL TRIAL APPLICATION IN BELGIUM, WHERE IT PLANS TO FIRST INITIATE PHASE 1, FIRST-IN-HUMAN CLINICAL TRIAL OF MCLA-158​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below